{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:31:24Z","timestamp":1791437484805,"version":"4.3.3"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007190","name":"Government Offices of Sweden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ebiom.2023.104452","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T13:54:41Z","timestamp":1675086881000},"page":"104452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4394-2634","authenticated-orcid":false,"given":"Artur","family":"Mezheyeuski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8804-1012","authenticated-orcid":false,"given":"Max","family":"Backman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Mart\u00edn-Bernab\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatarina","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Hrynchyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Str\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siarhei","family":"Mauchanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Khelashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8206-5294","authenticated-orcid":false,"given":"Amanda","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margr\u00e9t","family":"Agnarsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Henrik","family":"Edqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2685-0877","authenticated-orcid":false,"given":"Jutta","family":"Huvila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Segersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Uno","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Botling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Nodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotta","family":"Hedner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Br\u00e4ndstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sartor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Leandersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Glimelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Portyanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Ponten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Jirstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1210-5961","authenticated-orcid":false,"given":"Patrick","family":"Micke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Sj\u00f6blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ebiom.2023.104452_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1158\/2326-6066.CIR-16-0011","article-title":"Can targeting stroma pave the way to enhanced antitumor immunity and immunotherapy of solid tumors?","volume":"4","author":"Pure","year":"2016","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104452_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb3015","article-title":"The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis","volume":"16","author":"McAllister","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104452_bib4","first-page":"2474","article-title":"Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen","volume":"47","author":"Ziai","year":"1987","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104452_bib5","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1158\/1078-0432.CCR-22-0015","article-title":"Microenvironment is a key determinant of immune checkpoint inhibitor response","volume":"28","author":"Cho","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"10135","key":"10.1016\/j.ebiom.2023.104452_bib6","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet"},{"issue":"5795","key":"10.1016\/j.ebiom.2023.104452_bib7","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104452_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1158\/1078-0432.CCR-18-1851","article-title":"The immunoscore: colon cancer and beyond","volume":"26","author":"Angell","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56441-8","article-title":"The prognostic importance of CD20(+) B lymphocytes in colorectal cancer and the relation to other immune cell subsets","volume":"9","author":"Edin","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2023.104452_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fmed.2015.00033","article-title":"NK cell inflammation in the clinical outcome of colorectal carcinoma","volume":"2","author":"Coppola","year":"2015","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104452_bib11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ijc.30138","article-title":"Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer","volume":"139","author":"Berntsson","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ebiom.2023.104452_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.558169","article-title":"Topographical distribution and spatial interactions of innate and semi-innate immune cells in pancreatic and other periampullary adenocarcinoma","volume":"11","author":"Lundgren","year":"2020","journal-title":"Front Immunol"},{"issue":"6024","key":"10.1016\/j.ebiom.2023.104452_bib13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104452_bib14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104452_bib15","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: from basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J\u00a0Hematol Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"22","key":"10.1016\/j.ebiom.2023.104452_bib18","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1158\/0008-5472.CAN-16-2631","article-title":"A\u00a0milestone review on how macrophages affect tumor growth","volume":"76","author":"Caux","year":"2016","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/2326-6066.CIR-20-0527","article-title":"The prognostic role of macrophage polarization in the colorectal cancer microenvironment","volume":"9","author":"Vayrynen","year":"2021","journal-title":"Cancer Immunol Res"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104452_bib20","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-18-2076","article-title":"Tumor-associated macrophages as prognostic and predictive biomarkers for postoperative adjuvant chemotherapy in patients with stage II colon cancer","volume":"25","author":"Feng","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib21","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A\u00a0decade of immune-checkpoint inhibitors in cancer therapy","volume":"11","author":"Robert","year":"2020","journal-title":"Nat Commun"},{"issue":"6349","key":"10.1016\/j.ebiom.2023.104452_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104452_bib23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ccell.2018.04.001","article-title":"Tumor mutational burden and efficacy of nivolumab monotherapy and in combination with ipilimumab in small-cell lung cancer","volume":"33","author":"Hellmann","year":"2018","journal-title":"Cancer Cell"},{"issue":"6230","key":"10.1016\/j.ebiom.2023.104452_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104452_bib25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamaoncol.2019.1549","article-title":"Comparison of biomarker modalities for predicting response to PD-1\/PD-L1 checkpoint blockade: a systematic review and meta-analysis","volume":"5","author":"Lu","year":"2019","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/2326-6066.CIR-17-0360","article-title":"Quantitative analysis of immune infiltrates in primary melanoma","volume":"6","author":"Gartrell","year":"2018","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104452_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/0284186X.2017.1337926","article-title":"U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden","volume":"57","author":"Glimelius","year":"2018","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib38","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1021\/pr800745e","article-title":"Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma","volume":"8","author":"Stromberg","year":"2009","journal-title":"J\u00a0Proteome Res"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104452_bib39","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jtho.2016.01.020","article-title":"The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs","volume":"11","author":"Micke","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104452_bib43","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/bjc.2014.427","article-title":"The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer","volume":"111","author":"Hemdan","year":"2014","journal-title":"Br J Cancer"},{"issue":"42","key":"10.1016\/j.ebiom.2023.104452_bib40","doi-asserted-by":"crossref","first-page":"72108","DOI":"10.18632\/oncotarget.19437","article-title":"The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma","volume":"8","author":"Svensson","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ebiom.2023.104452_bib41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fonc.2019.00136","article-title":"Expression of PD-L1 and PD-1 in chemoradiotherapy-naive esophageal and gastric adenocarcinoma: relationship with mismatch repair status and survival","volume":"9","author":"Svensson","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2023.104452_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.534761","article-title":"Tumor-associated CD68(+), CD163(+), and MARCO(+) macrophages as prognostic biomarkers in patients with treatment-naive gastroesophageal adenocarcinoma","volume":"10","author":"Jeremiasen","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ebiom.2023.104452_bib46","first-page":"14","article-title":"Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival","volume":"3","author":"Nodin","year":"2010","journal-title":"J\u00a0Ovarian Res"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104452_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2015.03.055","article-title":"Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma","volume":"137","author":"Edqvist","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2018.02.016","article-title":"Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma","volume":"149","author":"Huvila","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104452_bib88","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2023.104452_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/srep36149","article-title":"Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer","volume":"6","author":"Mezheyeuski","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104452_bib27","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/ijc.32945","article-title":"Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinoma","volume":"146","author":"Lundgren","year":"2020","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.5026","article-title":"Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients","volume":"244","author":"Mezheyeuski","year":"2018","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ebiom.2023.104452_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103269","article-title":"The prognostic impact of the tumour stroma fraction: a machine learning-based analysis in 16 human solid tumour types","volume":"65","author":"Micke","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104452_bib48","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","article-title":"Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer","volume":"52","author":"Lee","year":"2020","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104452_bib30","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","article-title":"Phenotype molding of stromal cells in the lung tumor microenvironment","volume":"24","author":"Lambrechts","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41467-019-14256-1","article-title":"Single-cell analysis reveals new evolutionary complexity in uveal melanoma","volume":"11","author":"Durante","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13059-020-02210-0","article-title":"Single-cell transcriptome profiling of an adult human cell atlas of 15 major organs","volume":"21","author":"He","year":"2020","journal-title":"Genome Biol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104452_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","article-title":"Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma","volume":"39","author":"Bi","year":"2021","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib33","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1038\/s41598-021-84787-5","article-title":"Pancancer survival analysis of cancer hallmark genes","volume":"11","author":"Nagy","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104452_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/ERC-11-0329","article-title":"Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients","volume":"19","author":"Gyorffy","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"31","key":"10.1016\/j.ebiom.2023.104452_bib50","doi-asserted-by":"crossref","first-page":"49322","DOI":"10.18632\/oncotarget.10337","article-title":"Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients","volume":"7","author":"Szasz","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104452_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082241","article-title":"Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer","volume":"8","author":"Gyorffy","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","article-title":"Survival model predictive accuracy and ROC curves","volume":"61","author":"Heagerty","year":"2005","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/cjs.10046","article-title":"Estimation methods for time-dependent AUC models with survival data","volume":"38","author":"Hung","year":"2010","journal-title":"Can J Stat"},{"issue":"30","key":"10.1016\/j.ebiom.2023.104452_bib54","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41598-019-55013-0","article-title":"Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome","volume":"10","author":"Mezheyeuski","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib56","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1038\/s41598-021-87720-y","article-title":"Macrophages with reduced expressions of classical M1 and M2 surface markers in human bronchoalveolar lavage fluid exhibit pro-inflammatory gene signatures","volume":"11","author":"Takiguchi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2023.104452_bib57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1146\/annurev-immunol-032414-112220","article-title":"Macrophages: development and tissue specialization","volume":"33","author":"Varol","year":"2015","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104452_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-7771-2-1","article-title":"Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases","volume":"2","author":"Yang","year":"2014","journal-title":"Biomark Res"},{"key":"10.1016\/j.ebiom.2023.104452_bib59","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3389\/fimmu.2019.01642","article-title":"The ontogeny of monocyte subsets","volume":"10","author":"Wolf","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib60","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2018.10.005","article-title":"Developmental and functional heterogeneity of monocytes","volume":"49","author":"Guilliams","year":"2018","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104452_bib61","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri.2017.28","article-title":"Monocyte differentiation and antigen-presenting functions","volume":"17","author":"Jakubzick","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2023.104452_bib62","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human monocyte subsets and phenotypes in major chronic inflammatory diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104452_bib63","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.4049\/jimmunol.147.11.3988","article-title":"Gene expression of the A- and B-chain of mouse C1q in different tissues and the characterization of the recombinant A-chain","volume":"147","author":"Petry","year":"1991","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104452_bib64","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/2326-6066.CIR-18-0891","article-title":"Tumor cells Hijack macrophage-produced complement C1q to promote tumor growth","volume":"7","author":"Roumenina","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"11\u201312","key":"10.1016\/j.ebiom.2023.104452_bib65","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.molimm.2010.02.006","article-title":"Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis","volume":"47","author":"Castellano","year":"2010","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib66","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/gutjnl-2019-319292","article-title":"Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study","volume":"69","author":"Reichling","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2528","article-title":"Trophic macrophages in development and disease","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"6117","key":"10.1016\/j.ebiom.2023.104452_bib68","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.1232227","article-title":"Neutralizing tumor-promoting chronic inflammation: a magic bullet?","volume":"339","author":"Coussens","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104452_bib69","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104452_bib70","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.4049\/jimmunol.169.7.3978","article-title":"Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in\u00a0vivo and in\u00a0vitro: calreticulin and CD91 as a common collectin receptor complex","volume":"169","author":"Vandivier","year":"2002","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104452_bib71","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.4049\/jimmunol.1103760","article-title":"Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells","volume":"188","author":"Benoit","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"6388","key":"10.1016\/j.ebiom.2023.104452_bib72","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.aao4555","article-title":"C1q restrains autoimmunity and viral infection by regulating CD8(+) T cell metabolism","volume":"360","author":"Ling","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2023.104452_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10346","article-title":"C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation","volume":"7","author":"Bulla","year":"2016","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104452_bib74","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1373\/clinchem.2019.303644","article-title":"Biomarkers for predicting response to immunotherapy with immune checkpoint inhibitors in cancer patients","volume":"65","author":"Duffy","year":"2019","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104452_bib75","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib76","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14737167.2018.1467270","article-title":"Cost effectiveness vs. affordability in the age of immuno-oncology cancer drugs","volume":"18","author":"Dranitsaris","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"436","key":"10.1016\/j.ebiom.2023.104452_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan3311","article-title":"T\u00a0cell-induced CSF1 promotes melanoma resistance to PD1 blockade","volume":"10","author":"Neubert","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2023.104452_bib78","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ebiom.2016.02.024","article-title":"Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors","volume":"6","author":"Holmgaard","year":"2016","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104452_bib79","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat Biomed Eng"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib80","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1101204","article-title":"GM-CSF and ipilimumab therapy in metastatic melanoma: clinical outcomes and immunologic responses","volume":"5","author":"Kwek","year":"2016","journal-title":"Oncoimmunology"},{"issue":"17","key":"10.1016\/j.ebiom.2023.104452_bib81","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1001\/jama.2014.13943","article-title":"Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial","volume":"312","author":"Hodi","year":"2014","journal-title":"JAMA"},{"issue":"10197","key":"10.1016\/j.ebiom.2023.104452_bib82","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(19)30764-0","article-title":"Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial","volume":"394","author":"Tap","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104452_bib83","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/neuonc\/nov245","article-title":"Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study","volume":"18","author":"Butowski","year":"2016","journal-title":"Neuro Oncol"},{"issue":"22","key":"10.1016\/j.ebiom.2023.104452_bib84","doi-asserted-by":"crossref","first-page":"16213","DOI":"10.18632\/oncotarget.23806","article-title":"An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphoma","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104452_bib85","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104452_bib86","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10637-012-9869-8","article-title":"Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer","volume":"31","author":"Pienta","year":"2013","journal-title":"Invest New Drugs"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104452_bib87","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/1078-0432.CCR-14-1845","article-title":"An open-label, multicenter, phase I\/II study of JNJ-40346527, a CSF-1R inhibitor, in patients with relapsed or refractory Hodgkin lymphoma","volume":"21","author":"von Tresckow","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423000178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423000178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:20:48Z","timestamp":1762456848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423000178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":88,"alternative-id":["S2352396423000178"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104452","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104452"}}